Long-term risks for kidney donors

Kidney International

Volumn 86, Issue 1, 2014, Pages 162-167

  Mjøen, Geir ^a   Hallan, Stein ^b,c   Hartmann, Anders ^a   Foss, Aksel ^a   Midtvedt, Karsten ^a   Øyen, Ole ^a   Reisæter, Anna ^a   Pfeffer, Per ^a   Jenssen, Trond ^a   Leivestad, Torbjørn ^a   Line, Pål Dag ^a   Øvrehus, Magnus ^b   Dale, Dag Olav ^a   Pihlstrøm, Hege ^a   Holme, Ingar ^a   Dekker, Friedo W ^d   Holdaas, Hallvard ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

cardiovascular events; end stage kidney disease; kidney donation; kidney transplantation; mortality risk

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; END STAGE RENAL DISEASE; FEMALE; FIRST DEGREE RELATIVE; FOLLOW UP; HEALTH HAZARD; HUMAN; INCIDENCE; KIDNEY DONOR; KIDNEY FUNCTION; LIVING DONOR; MALE; PRIORITY JOURNAL; RELATIVE; SURVIVAL RATE; UNRELATED DONORS; ADVERSE EFFECTS; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; CAUSE OF DEATH; EPIDEMIOLOGY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MIDDLE AGED; MORTALITY; NORWAY; PROPORTIONAL HAZARDS MODEL; TRANSPLANTATION;

ADULT; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; NORWAY; PROPORTIONAL HAZARDS MODELS; TISSUE AND ORGAN HARVESTING;

EID: 84903689681     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.460     Document Type: Article

References (27)

1. Cohen DJ, St Martin L, Christensen LL et al. Kidney and pancreas transplantation in the United States, 1995-2004. Am J Transplant 2006; 6: 1153-1169.
2. Middleton PF, Duffield M, Lynch SV et al. Living donor liver transplantation-Adult donor outcomes: A systematic review. Liver Transpl 2006; 12: 24-30.
3. Segev DL, Muzaale AD, Caffo BS et al. Perioperative mortality and longterm survival following live kidney donation. JAMA 2010; 303: 959-966.
4. Mjoen G, Oyen O, Holdaas H et al. Morbidity and mortality in 1022 consecutive living donor nephrectomies: Benefits of a living donor registry. Transplantation 2009; 88: 1273-1279.
5. Boudville N, Prasad GV, Knoll G et al. Meta-Analysis: Risk for hypertension in living kidney donors. Ann Intern Med 2006; 145: 185-196. (Pubitemid 46780564)
6. Garg AX, Muirhead N, Knoll G et al. Proteinuria and reduced kidney function in living kidney donors: A systematic review, meta-Analysis, and meta-regression. Kidney Int 2006; 70: 1801-1810. (Pubitemid 44684812)
7. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
8. Matsushita K, van d V, Astor BC et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-Analysis. Lancet 2010; 375: 2073-2081.
9. Tonelli M, Wiebe N, Culleton B et al. Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol 2006; 17: 2034-2047. (Pubitemid 44036188)
10. Fehrman-Ekholm I, Elinder CG, Stenbeck M et al. Kidney donors live longer. Transplantation 1997; 64: 976-978. (Pubitemid 27446761)
11. Ibrahim HN, Foley R, Tan L et al. Long-Term consequences of kidney donation. N Engl J Med 2009; 360: 459-469.
12. Mjoen G, Reisaeter A, Hallan S et al. Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population. Nephrol Dial Transplant 2012; 27: 443-447.
13. Garg AX, Prasad GV, Thiessen-Philbrook HR et al. Cardiovascular disease and hypertension risk in living kidney donors: An analysis of health administrative data in Ontario, Canada. Transplantation 2008; 86: 399-406.
14. Garg AX, Meirambayeva A, Huang A et al. Cardiovascular disease in kidney donors: Matched cohort study. BMJ 2012; 344: E1203.
15. Fournier C, Pallet N, Cherqaoui Z et al. Very long-Term follow-up of living kidney donors. Transpl Int 2012; 25: 385-390.
16. Kido R, Shibagaki Y, Iwadoh K et al. How do living kidney donors develop end-stage renal disease? Am J Transplant 2009; 9: 2514-2519.
17. Lin J, Kramer H, Chandraker AK. Mortality among living kidney donors and comparison populations. N Engl J Med 2010; 363: 797-798.
18. Cherikh WS, Young CJ, Kramer BF et al. Ethnic and gender related differences in the risk of end-stage renal disease after living kidney donation. Am J Transplant 2011; 11: 1650-1655.
19. Fehrman-Ekholm I, Norden G, Lennerling A et al. Incidence of end-stage renal disease among live kidney donors. Transplantation 2006; 82: 1646-1648. (Pubitemid 46035644)
20. Freedman BI, Volkova NV, Satko SG et al. Population-based screening for family history of end-stage renal disease among incident dialysis patients. Am J Nephrol 2005; 25: 529-535. (Pubitemid 41816046)
21. Mjoen G, Stavem K, Westlie L et al. Quality of life in kidney donors. Am J Transplant 2011; 11: 1315-1319.
22. Delmonico FA. Report of the Amsterdam Forum on the care of the live kidney donor: Data and medical guidelines. Transplantation 2005; 79: S53-S66.
23. Levey AS, Stevens LA. Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: More accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis 2010; 55: 622-627.
24. Sterne JA, White IR, Carlin JB et al. Multiple imputation for missing data in epidemiological and clinical research: Potential and pitfalls. BMJ 2009; 338: B2393.
25. Blackwell M, Iacus S, King G et al. CEM: Coarsened exact matching in Stata. Stata J Nephrol 2009; 9: 524-546.
26. Fine JP, Gray RJ. A proportion hazards model for the subdistribution of a competing risk. J Am Stat Ass 1999; 94: 496-509.
27. Kleinbaum DG, Klein M. Survival analysis: A Self-learning Text, 3rd edn., 2012. Springer: New York, Dordrecht, Heideberg, London.